Melatonin in Athletes: What the Evidence Actually Supports for Sleep, Recovery, and Performance
Table of Contents
Key Takeaways: Melatonin in Athletes
- Melatonin is primarily a sleep and circadian-timing aid, not an established performance-enhancing or recovery supplement.
- Its most defensible uses in athletes are managing jet lag and addressing an identifiable difficulty with sleep or sleep timing.
- If melatonin improves recovery or performance by improving sleep, that benefit is likely indirect rather than a direct ergogenic effect.
- Evening administration and longer intervals before exercise have been associated with more favorable endurance and explosive-power outcomes, but these subgroup findings do not prove that timing caused the differences.
- Melatonin may improve time-to-exhaustion performance, but a benefit for self-paced time-trial performance has not been established.
- Lower creatine kinase levels do not necessarily mean less soreness, faster functional recovery, or better performance in the next training session.
- Taking melatonin shortly before exercise has no clearly established benefit and may reduce alertness through its sedating effect.
- For competition travel, melatonin may support adjustment to a new time zone, but it cannot replace early arrival and sufficient time for natural circadian adaptation.
- Commercial products may contain substantially more or less melatonin than stated on the label, making product quality an important consideration.
Introduction: Melatonin in Athletes
Melatonin is widely used by people dealing with difficulty sleeping, disrupted work schedules, or jet lag. In Finland, some preparations are available without a prescription, making melatonin relatively easy to obtain. Its accessibility and generally favorable short-term safety profile can make it a reasonable option to consider early, depending on the underlying sleep problem. However, easy availability does not mean that melatonin is suitable for everyone or free from clinically relevant interactions. Other medications, underlying health conditions, and the actual cause of the sleep disturbance still matter.
In the sleep clinic where I work, we mainly use prolonged-release melatonin when the aim is to support sleep across the night. It releases melatonin more gradually, whereas immediate-release melatonin has a shorter duration of action and may be considered when the problem relates more to sleep timing or falling asleep. This is our clinical approach rather than a rule for every patient, and the expected benefit of either formulation is usually modest rather than dramatic.
Athletes generally use melatonin for the same reasons as anyone else: difficulty sleeping, irregular schedules, or travel across time zones. In my view, it is important not to create a separate “athlete indication” where one does not exist. Athletes may place greater emphasis on sleep because of its relevance to training and recovery, but the underlying reason for considering melatonin remains much the same as it would for a shift worker or frequent traveler.
Even so, melatonin appears to be relatively common in some endurance-sport populations. A cross-sectional survey of 200 recreationally competitive cyclists, runners, and triathletes placed it among the ten most commonly reported supplements in that sample, alongside multivitamins, electrolytes, and protein [10]. It is marketed not only for sleep before competition but also for faster recovery and improved performance. The research picture is more nuanced: newer evidence suggests that timing may help explain how melatonin relates to exercise performance and muscle-damage markers, but the observed patterns are not proof that timing itself causes these differences, and the underlying mechanisms remain uncertain [1][11].
The Problem: Timing Confusion Around Melatonin in Athletes
Athletes face a distinct set of sleep disruptors: late-evening competition, travel across time zones, pre-competition anxiety, and training schedules that don’t align with a normal light-dark cycle. Melatonin is the neurohormone secreted by the pineal gland that helps regulate the timing of the sleep-wake cycle, and its release is tightly coupled to light exposure, reaching its lowest point in the morning and its highest at night [6]. Because exogenous melatonin can influence when this internal clock is set, it’s marketed to athletes as a way to fall asleep faster before an early flight, adjust to a new time zone, or wind down after a late match.
The confusion around melatonin in athletes arises because “melatonin for athletes” gets used as a catch-all term covering three genuinely different applications — sleep-timing support at night, jet lag mitigation around travel, and exercise-related dosing for a purported performance or recovery boost — and the evidence for each is quite different, and for the exercise-related use, the picture is more complicated still.
In Finland, melatonin is generally understood as a sleep-timing aid rather than a performance-enhancing substance. In my experience, athletes mainly use it to help them fall asleep before competition, manage changes in time zone, or address an ongoing difficulty with sleep initiation. Some use it regularly, but these are not athlete-specific indications. From a clinical perspective, the relevant question is not whether the person is an athlete, but whether there is a sleep or circadian-timing problem that melatonin may reasonably help address.
Mechanisms Behind Melatonin in Athletes: Sleep Regulation, Antioxidant Action, and Thermoregulation
Beyond its role in circadian timing, melatonin functions as a potent free-radical scavenger and antioxidant, and this dual identity — chronobiotic hormone and antioxidant molecule — is what generates most of the athlete-specific interest [6][7]. Intensive exercise increases production of reactive oxygen and nitrogen species in skeletal muscle, contributing to the oxidative and inflammatory load that the body has to recover from after a hard session [6].
Dose-response evidence from a meta-analysis of 26 randomized controlled trials (1,689 observations, trials published 1987–2020) in people with insomnia and healthy volunteers suggests that administration roughly 3 hours before the desired bedtime may produce a larger average sleep-promoting effect than the commonly used 2 mg taken 30 minutes before bed, with effect size increasing progressively with dose up to around 4 mg/day [3]. This wasn’t an athlete-specific study, and it hasn’t been established as an individual or athlete-specific optimum — it reflects an average pattern across studies with different timing and dosing, not a systematic within-person comparison [3].
Separately, melatonin has a measurable hypothermic effect. In a controlled crossover trial, a single 2.5 mg dose attenuated the exercise-induced rise in core temperature during 66 minutes of intermittent exercise under moderate heat stress, without affecting subjective alertness, sleepiness, perceived exertion, or thermal strain [9]. Whether this effect meaningfully improves endurance performance in the heat remains unconfirmed — the trial did not measure performance outcomes, only thermoregulatory and subjective variables [9].
From a clinical perspective, melatonin’s antioxidant and hypothermic effects remain more physiologically interesting than practically useful. Their existence does not necessarily mean that they produce a meaningful improvement in performance, recovery, or heat tolerance. In my experience, patients and athletes rarely use melatonin specifically for either of these effects; its practical role remains centered on sleep and circadian timing. I therefore see these mechanisms mainly as useful biological context rather than established clinical indications.
Performance and Recovery Impact of Melatonin in Athletes: Timing May Help Explain the Different Findings
A 2026 systematic review and meta-analysis of 19 randomized controlled trials (266 participants, searches current through September 2025) examined timing as a possible explanation for melatonin’s inconsistent performance findings, through a set of prespecified subgroup analyses [11]. It’s worth being precise about what that method can and can’t show: the trials in each timing subgroup weren’t the same trials given at different times — they were different studies that happened to use different timing, so the comparisons are associative, not a controlled test of timing itself. With that caveat in place, the pattern is still informative.
Acute dosing close to exercise does not reliably help. An earlier systematic review of ten controlled trials found that acute melatonin taken shortly before exercise produced no improvement in speed or short-duration continuous exercise, and in two of seven strength/power trials it actually reduced performance [1]. The 2026 meta-analysis reports a broadly compatible pattern: in the subgroup of studies dosing 2 hours or less before exercise, there was no statistically significant benefit for endurance (SMD 0.36, 95% CI −0.02 to 0.74) or explosive power (SMD 0, no effect at all) [11]. For endurance, the confidence interval is close to crossing zero but doesn’t rule out a real effect, so this reads as “not established” rather than “disproven” — a statistically non-significant result in a small subgroup isn’t the same as proof of no effect. The 2026 review characterized one included trial as showing reduced power output and increased fatigue after an 8 mg daytime pre-exercise dose, attributing it to reduced alertness [11]; a separate, dedicated systematic review of melatonin in soccer players describes what appears to be the same underlying study somewhat differently — different test timing and outcome measures — so this specific example should be read as one review’s characterization rather than an independently cross-verified fact.
Subgroup analyses suggested larger effects with evening administration, intervals longer than 6 hours, and multi-day dosing. For endurance, the overall effect was SMD 0.58, while estimates were larger with evening dosing (SMD 0.73) and intervals exceeding 6 hours (SMD 0.80) [11]. However, these were comparisons between different studies, no formal interaction tests were reported, and the subgroups differed in dose, population, and test type. The findings therefore suggest a timing-related pattern but do not establish timing as the cause.
Melatonin improved time-to-exhaustion performance (SMD 0.62) but not self-paced time-trial performance (SMD 0.38, not statistically significant) [11]. This may indicate an effect on tolerance to a fixed-intensity exercise bout, but it does not demonstrate better recovery, greater tolerance of a training block, or improved long-term adaptation. No significant benefits were found for speed or maximal strength, and three included trials reported drowsiness or reduced alertness after daytime dosing [11].
On muscle damage biomarkers, the 2026 meta-analysis found a reduction in creatine kinase (CK) with melatonin, based on seven comparisons and 91 participants (SMD 0.59, rated high certainty) [11]. This is an overall pooled result — the review did not report a timing-based subgroup analysis for CK specifically (unlike its endurance and explosive-power outcomes), so this finding shouldn’t be read as tied to evening dosing or any other particular timing [11]. The review also noted mild funnel-plot asymmetry suggesting small positive studies may be somewhat overrepresented in that literature. This is broadly consistent with earlier findings: a study of trained men completing a 50 km mountain run with roughly 2,800 meters of elevation gain found melatonin reduced oxidative stress markers and blunted the exercise-induced rise in inflammatory mediators and regulators including TNF-α, IL-6, and IL-1ra [5], and the eight-study soccer review found reduced oxidative stress in five of eight studies and attenuated muscle damage in three [7]. Effects on lactate dehydrogenase were smaller and not statistically significant (SMD 0.45, p=0.07, rated moderate certainty) [11], and a positive signal for AST (SMD 0.99) was rated very-low-certainty due to a small number of studies (four) and suspected publication bias [11] — worth flagging since it’s the least reliable number in this literature.
What this doesn’t yet establish, even with the stronger 2026 evidence: whether these effects — the time-to-exhaustion improvement, the CK reduction — translate into an athlete recovering faster, feeling less soreness, or performing better in a subsequent session days later. The included trials were short, mostly small (10–30 participants per study), predominantly male, and didn’t track longer-term training adaptation [11]. That’s a real evidence gap, not a technicality — it’s the difference between “this changes physiologically” and “this makes you race better next week.”
Overall, melatonin is not generally regarded as a clinically established performance or recovery aid. In practice, its main role remains the management of sleep or circadian-timing problems. If melatonin improves an athlete’s sleep, that improvement may indirectly support performance and recovery, but this is different from melatonin acting as an ergogenic substance in its own right.
From a clinical perspective, I would mainly consider melatonin when an athlete has an identifiable difficulty with sleep, travel-related circadian disruption, or a similar sleep-timing problem. If an athlete already sleeps well, there is much less reason to expect a meaningful additional benefit. Using melatonin solely to enhance performance appears difficult to justify, particularly close to exercise, when its sedating effect may reduce alertness. To me, taking a sleep-promoting substance immediately before a performance task is inherently counterintuitive unless there is a separate, clearly defined reason for doing so.
Sleep Deprivation Is a Distinct Scenario for Melatonin in Athletes
One trial specifically tested melatonin’s effect in the scenario many athletes actually face: performing after a poor night’s sleep. Ten collegiate student-athletes completed a randomized, double-blind crossover trial comparing 6 mg of melatonin against placebo, administered 30 minutes before testing, under three sleep conditions — normal sleep, 4 hours of sleep deprivation, and 24 hours of sleep deprivation [2]. In this small trial, melatonin did not significantly change reaction time, anaerobic power, or balance under normal-sleep conditions. But following 24 hours of sleep deprivation, melatonin significantly improved anaerobic power and reaction time compared with placebo, and it reduced the negative impact of 4-hour sleep deprivation on balance [2]. The authors concluded that pre-training melatonin may help offset the neurological and physical performance decline caused by sleep deprivation specifically, with a larger apparent benefit after longer deprivation — but they also noted the trial’s small sample size (n=10) as a limitation [2].
This trial’s well-rested-condition result shouldn’t be read as a broader claim that melatonin has no ergogenic value under any well-rested condition — the 2026 endurance and CK findings above suggest otherwise under specific timing. What this trial does suggest is a distinct, preliminary situational benefit when sleep loss itself is the problem being addressed, based on this single small study.
These findings may seem clinically counterintuitive, particularly because melatonin can cause drowsiness. The key point, however, is that the apparent benefits emerged under experimentally induced sleep-deprivation conditions rather than under normal, well-rested conditions. The results therefore cannot be generalized to an athlete who has slept normally before training or competition.
In my view, this small study is best treated as a scientifically interesting observation rather than evidence that is ready to guide practice. With only ten participants, it cannot establish a reliable clinical indication or support a recommendation to take melatonin before exercise following sleep loss. I would be very cautious about allowing a single small trial to influence clinical decision-making, especially when its findings appear counterintuitive and have not yet been established in larger studies.
Jet Lag: A Better-Supported Use Case for Melatonin in Athletes
For athletes traveling across time zones, jet lag is among the better-supported practical applications of melatonin. The Cochrane systematic review of ten randomized trials in airline passengers, airline staff, and military personnel — not athletes specifically, though the underlying circadian-disruption problem is the same — found that melatonin taken close to the target bedtime at the destination (10 p.m. to midnight) reduced jet lag in eight of the ten trials, specifically for flights crossing five or more time zones, and concluded that occasional short-term use appeared safe [4]. The review’s authors recommended melatonin particularly for eastward travel and for travelers with a history of jet lag on previous trips, noting that travelers crossing two to four time zones could also use it if needed [4]. This review dates to 2002 and is built substantially on smaller, older trials in non-athlete populations, so it should be read as among the better-supported applications rather than definitive by current standards.
Jet lag is one of the situations in which melatonin may have a well-founded practical role, and I have seen both patients and athletes use it successfully when adjusting to a new time zone. Even so, when an athlete is travelling across several time zones for an important competition, my primary advice is usually to arrive early enough to allow time for natural circadian adjustment.
Melatonin may help support that transition, but it cannot fully compensate for a travel schedule that leaves too little time to adapt. In practice, planning the journey so that the athlete has sufficient time at the destination before competing may be more important than relying on any single sleep aid. I therefore see melatonin as a potentially useful part of the adjustment strategy rather than a substitute for adequate preparation and sensible travel planning.
Conclusion: Melatonin in Athletes
Melatonin is best understood as a sleep and circadian-timing aid rather than a performance-enhancing or recovery supplement. Research has identified antioxidant, thermoregulatory, and muscle-damage-marker effects, as well as potentially favorable performance findings with evening or delayed dosing. However, much of this evidence comes from small, short-term studies, and the timing patterns are based largely on comparisons between different trials rather than direct head-to-head testing. Improvements in time-to-exhaustion or reductions in creatine kinase also do not establish faster recovery, better subsequent performance, or improved long-term training adaptation. Taking melatonin close to exercise appears particularly difficult to justify, as a clear benefit has not been established and daytime dosing may reduce alertness.
In my clinical practice, the most defensible reasons for an athlete to use melatonin are the same as for anyone else: managing jet lag, supporting circadian adjustment, or addressing an identifiable difficulty with sleep. When travelling for competition, melatonin may support the transition to a new time zone, but it cannot replace sensible travel planning or sufficient time to adjust before competing. If melatonin improves an athlete’s sleep, that improvement may indirectly support recovery and performance. Beyond these sleep-related applications, however, neither the current evidence nor my clinical experience provides a strong basis for recommending melatonin as a direct ergogenic or recovery aid. Its practical value lies in solving a genuine sleep or circadian problem—not in adding another supplement to an athlete’s performance routine.
References
1 https://doi.org/10.1177/19417381231155142
2 https://doi.org/10.5812/intjsh.110657
3 https://doi.org/10.1111/jpi.12985
4 https://doi.org/10.1002/14651858.CD001520
5 https://pubmed.ncbi.nlm.nih.gov/21615492/
6 https://pmc.ncbi.nlm.nih.gov/articles/PMC11013451/
7 https://pmc.ncbi.nlm.nih.gov/articles/PMC10610359/
9 https://doi.org/10.1111/j.1600-079X.2005.00256.x
